Filtered By:
Infectious Disease: Hepatitis B
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 12613 results found since Jan 2013.
Antioxidants and Calcium Modulators Preclude in Vitro Hepatitis B Virus-Induced Mitochondrial Damage
CONCLUSIONS: Current study indicates that the mitochondrial fragmentation induced by hepatitis B virus infection can be reduced after antioxidant treatment pointing toward exploring better drug targets for the prevention of hepatitis B virus-induced mitochondrial frag- mentation and associated liver damage.PMID:37565795 | DOI:10.5152/tjg.2023.21290
Source: The Turkish Journal of Gastroenterology - August 11, 2023 Category: Gastroenterology Authors: Kehkshan Jabeen Aneela Javed Sobia Manzoor Shaheen Shahzad Source Type: research
Direct and crowding-out effects of a Hepatitis B vaccination campaign
Econ Hum Biol. 2023 Jul 23;51:101279. doi: 10.1016/j.ehb.2023.101279. Online ahead of print.ABSTRACTWe evaluate the direct and spillover causal effects of a Hepatitis B (HB) vaccination campaign in French schools on the vaccination adherence of the targeted pupils. Using a regression discontinuity design, we show that this campaign created an exogenous shock on vaccination behavior, increasing the HB vaccination rate for children aged 11 and above. At the same time, we show a drop in the measles, mumps, and rubella (MMR) vaccination rate of the targeted pupils and an increase in the parental belief that measles is a benign...
Source: Economics and Human Biology - August 11, 2023 Category: Biology Authors: Cl émentine Garrouste Arthur Juet Anne-Laure Samson Source Type: research
Antioxidants and Calcium Modulators Preclude in Vitro Hepatitis B Virus-Induced Mitochondrial Damage
CONCLUSIONS: Current study indicates that the mitochondrial fragmentation induced by hepatitis B virus infection can be reduced after antioxidant treatment pointing toward exploring better drug targets for the prevention of hepatitis B virus-induced mitochondrial frag- mentation and associated liver damage.PMID:37565795 | DOI:10.5152/tjg.2023.21290
Source: The Turkish Journal of Gastroenterology - August 11, 2023 Category: Gastroenterology Authors: Kehkshan Jabeen Aneela Javed Sobia Manzoor Shaheen Shahzad Source Type: research
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
Haematologica. 2023 Aug 10. doi: 10.3324/haematol.2023.283723. Online ahead of print.ABSTRACTClinical trial eligibility criteria can unfairly exclude patients or unnecessarily expose them to known risks if criteria are not concordant with drug safety. There are few data evaluating the extent to which acute leukemia eligibility criteria are justified. We analyzed criteria and drug safety data for front-line phase II and/or III acute leukemia trials with start dates 1/1/2010-12/31/2019 registered on ClinicalTrials.gov. Multivariable analyses assessed concordance between criteria use and safety data (presence of criteria with...
Source: Haematologica - August 10, 2023 Category: Hematology Authors: Andrew Hantel Marlise R Luskin Irum Khan Elizabeth Warner Anand A Patel Thomas P Walsh Daniel J DeAngelo Christopher S Lathan Gregory A Abel Source Type: research
Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study
CONCLUSIONS: Our approach provides decision-makers with a valuable tool to better understand local patterns of untimely childhood vaccination and identify districts where strengthening vaccine delivery systems could have the greatest impact.PMID:37563051 | DOI:10.1016/j.vaccine.2023.08.004
Source: Vaccine - August 10, 2023 Category: Allergy & Immunology Authors: Oghenebrume Wariri Chigozie Edson Utazi Uduak Okomo C Jessica E Metcalf Malick Sogur Sidat Fofana Kris A Murray Chris Grundy Beate Kampmann Source Type: research
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
Haematologica. 2023 Aug 10. doi: 10.3324/haematol.2023.283723. Online ahead of print.ABSTRACTClinical trial eligibility criteria can unfairly exclude patients or unnecessarily expose them to known risks if criteria are not concordant with drug safety. There are few data evaluating the extent to which acute leukemia eligibility criteria are justified. We analyzed criteria and drug safety data for front-line phase II and/or III acute leukemia trials with start dates 1/1/2010-12/31/2019 registered on ClinicalTrials.gov. Multivariable analyses assessed concordance between criteria use and safety data (presence of criteria with...
Source: Haematologica - August 10, 2023 Category: Hematology Authors: Andrew Hantel Marlise R Luskin Irum Khan Elizabeth Warner Anand A Patel Thomas P Walsh Daniel J DeAngelo Christopher S Lathan Gregory A Abel Source Type: research
Laparoscopic Anatomical Liver Resection of Segment VIII by Using ICG Fluorescence Positive Staining Under the Guidance of Laparoscopic Ultrasonography
CONCLUSIONS: Laparoscopic anatomical liver resection of S8 has been demonstrated to be feasible. Under the guidance of laparoscopic ultrasonography, ICG positive staining was proven to be optimal for Anatomical segmentectomy.PMID:37556011 | DOI:10.1245/s10434-023-13920-7
Source: Ann Oncol - August 9, 2023 Category: Cancer & Oncology Authors: Ji Sun Zhi-Yu Lu Jian-Xin Zhai Meng-Ran Lang Hong-Guang Wang Source Type: research
